With US$361 million awarded to 92 projects funding, CARB-X closed the fifth fiscal year since inception. In 2021, CARB-X invested in 25 new projects…
Diagnostics company Ares Genetics GmbH, developing NGS- and AI-powered solutions to combat AMR, has successfully completed Phase 1 of its collaboration with a leading…